Indian pharma exports set to have double digit growth in FY17

10 February 2017

India’s pharmaceutical exports have done better than many sectorial exports and are in near double digit growth, according to a government official.

“Last month, growth has also been good; it is about 8%. So I see that despite overall contraction and slowdown, pharma exports doing relatively better. I don't think that it (double digit growth) would be possible," said Sudhanshu Pandey, Joint Secretary, Ministry of Commerce, according to a web posting by Brand India Pharma, an initiative led by Pharmexcil (Pharmaceutical Export Promotion Council) and IBEF (India Brand Equity Foundation) under the aegis of the Department of Commerce.

Pharmaceutical exports were around $16.9 billion in 2015-16, a growth rate of 9.44% from previous year. In terms of international trends, Brexit - the UK’s move to leave the European Union - has not had such a great impact on pharma exports to Britain and other geographies as exports have stabilized in these regions.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK